Indraprastha Medical Stock Fundamentals
| INDRAMEDCO | 459.75 22.90 5.24% |
Indraprastha Medical fundamentals help investors to digest information that contributes to Indraprastha Medical's financial success or failures. It also enables traders to predict the movement of Indraprastha Stock. The fundamental analysis module provides a way to measure Indraprastha Medical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Indraprastha Medical stock.
At present, Indraprastha Medical's EBITDA is projected to increase significantly based on the last few years of reporting. The current year's Cost Of Revenue is expected to grow to about 8.3 B, whereas Interest Expense is forecasted to decline to about 35.6 M. Indraprastha | Select Account or Indicator |
Indraprastha Medical Company Profit Margin Analysis
Indraprastha Medical's Profit Margin measures overall efficiency of a company and shows its ability to withstand competition as well as defend against adverse conditions such as rising costs, falling prices, decline in sales or management distress. Profit margin tells investors how well the company executes on its overall pricing strategies as well as how effective the company in controlling its costs.
Current Indraprastha Medical Profit Margin | 0.11 % |
Most of Indraprastha Medical's fundamental indicators, such as Profit Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Indraprastha Medical is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, Profit Margin indicator shows the amount of money the company makes from total sales or revenue. It can provide a good insight into companies in the same sector, as well as help to identify trends of a company from year to year.
| Competition |
Based on the latest financial disclosure, Indraprastha Medical has a Profit Margin of 0.1121%. This is 101.0% lower than that of the Health Care Providers & Services sector and significantly higher than that of the Health Care industry. The profit margin for all India stocks is 108.83% lower than that of the firm.
Indraprastha Medical Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Indraprastha Medical's current stock value. Our valuation model uses many indicators to compare Indraprastha Medical value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Indraprastha Medical competition to find correlations between indicators driving Indraprastha Medical's intrinsic value. More Info.Indraprastha Medical is currently regarded as number one stock in return on equity category among its peers. It also is currently regarded as number one stock in return on asset category among its peers reporting about 0.50 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Indraprastha Medical is roughly 2.00 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Indraprastha Medical's earnings, one of the primary drivers of an investment's value.Indraprastha Profit Margin Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Indraprastha Medical's direct or indirect competition against its Profit Margin to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Indraprastha Medical could also be used in its relative valuation, which is a method of valuing Indraprastha Medical by comparing valuation metrics of similar companies.Indraprastha Medical is currently under evaluation in profit margin category among its peers.
Indraprastha Fundamentals
| Return On Equity | 0.31 | ||||
| Return On Asset | 0.16 | ||||
| Profit Margin | 0.11 % | ||||
| Operating Margin | 0.15 % | ||||
| Current Valuation | 39.46 B | ||||
| Shares Outstanding | 91.67 M | ||||
| Shares Owned By Insiders | 56.39 % | ||||
| Price To Book | 8.04 X | ||||
| Price To Sales | 3.23 X | ||||
| Revenue | 12.45 B | ||||
| Gross Profit | 6.35 B | ||||
| EBITDA | 2.1 B | ||||
| Net Income | 1.24 B | ||||
| Total Debt | 339.5 M | ||||
| Book Value Per Share | 57.27 X | ||||
| Cash Flow From Operations | 2 B | ||||
| Earnings Per Share | 16.14 X | ||||
| Target Price | 49.0 | ||||
| Number Of Employees | 2.98 K | ||||
| Beta | 0.81 | ||||
| Market Capitalization | 42.31 B | ||||
| Total Asset | 7.23 B | ||||
| Retained Earnings | 3.56 B | ||||
| Working Capital | 1.43 B | ||||
| Annual Yield | 0.01 % | ||||
| Net Asset | 7.23 B |
About Indraprastha Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Indraprastha Medical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Indraprastha Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Indraprastha Medical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.| Last Reported | Projected for Next Year | ||
| Current Deferred Revenue | 88 M | 160 M | |
| Total Revenue | 12.4 B | 7.2 B | |
| Cost Of Revenue | 7.9 B | 8.3 B |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Indraprastha Stock
Indraprastha Medical financial ratios help investors to determine whether Indraprastha Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Indraprastha with respect to the benefits of owning Indraprastha Medical security.